
ROC-325
CAS No. 1859141-26-6
ROC-325( ROC 325 | ROC325 )
Catalog No. M12869 CAS No. 1859141-26-6
ROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 61 | Get Quote |
![]() ![]() |
5MG | 87 | Get Quote |
![]() ![]() |
10MG | 150 | Get Quote |
![]() ![]() |
25MG | 303 | Get Quote |
![]() ![]() |
50MG | 492 | Get Quote |
![]() ![]() |
100MG | 710 | Get Quote |
![]() ![]() |
500MG | 1467 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameROC-325
-
NoteResearch use only, not for human use.
-
Brief DescriptionROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy.
-
DescriptionROC-325 (ROC 325, ROC325) is a novel, orally available inhibitor of lysosomal-mediated autophagy; exhibits superior in vitro anticancer effects compared with the existing autophagy inhibitor hydroxychloroquine (HCQ) in different cancer cell lines, including accumulation of autophagosomes with undegraded cargo, lysosomal deacidification, p62 stabilization, and disruption of autophagic flux; antagonizes RCC growth and survival in an ATG5/7-dependent manner, induces apoptosis and exhibited favorable selectivity; significantly more effective at inhibiting tumor progression than HCQ, and inhibited autophagy in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsROC 325 | ROC325
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1859141-26-6
-
Formula Weight503.061
-
Molecular FormulaC28H27ClN4OS
-
Purity>98% (HPLC)
-
SolubilityDMSO : 32 mg/mL 63.61 mM; H2O : < 0.1 mg/mL
-
SMILESO=C1C2=C(C(C)=CC=C2NCCN(C)CCNC3=C(C=CC(Cl)=C4)C4=NC=C3)SC5=CC=CC=C51
-
Chemical Name1-((2-((2-((7-chloroquinolin-4-yl)amino)ethyl)(methyl)amino)ethyl)amino)-4-methyl-9H-thioxanthen-9-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Carew JS, et al. Clin Cancer Res. 2017 Jun 1;23(11):2869-2879.
2. Carew JS, et al. Autophagy. 2017 Apr 3;13(4):765-766.
molnova catalog



related products
-
CUR5g
CUR5g is an autophagy inhibitor that inhibits migration and colony formation in A549 cells and acts through a UVRAG-dependent mechanism by blocking the recruitment of STX17 to autophagosomes.
-
Sulfacetamide sodium...
Sulfacetamide sodium monohydrate is a sulfonamide antibiotic, has been investigated for use in the treatment of pityriasis versicolor and rosacea.
-
O4I1
O4I1 is an effective Oct3/4 inducer.